Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Goldman Sachs sets Pluxee neutral with €30.5 target

EditorEmilio Ghigini
Published 02/06/2024, 05:54 AM
Updated 02/06/2024, 05:54 AM
© Reuters.

On Tuesday, Goldman Sachs initiated coverage of Pluxee, a leading company in the employee benefits and engagement sector, with a Neutral rating and a 12-month price target of €30.5. This target suggests a modest 4% potential upside from the current level.

Pluxee has experienced significant growth in recent years, with an approximately 19% organic revenue compound annual growth rate (CAGR) from fiscal year 2022 to 2023. This growth has been largely driven by the favorable economic environment of higher inflation and interest rates. However, Goldman Sachs analysts forecast a shift in these economic conditions, anticipating that the benefits Pluxee has reaped from inflation will diminish and that rising interest rates will begin to pose a challenge to the company's Float Revenue.

Despite the expected decrease in macroeconomic tailwinds, Pluxee is predicted to continue its growth, albeit at a slower pace. Goldman Sachs projects an 8% revenue CAGR for Pluxee from fiscal year 2024 to 2028. This estimate is slightly lower than that of Pluxee's closest peer, Edenred (EPA:EDEN), which is expected to grow at approximately 10% according to Goldman Sachs estimates (GSe).

The outlook for Pluxee also takes into account the company's enhanced product offerings and commercial strategy. While the immediate macroeconomic factors such as inflation and interest rates are evolving, the company's underlying business strategies are expected to support its ongoing growth in the coming years.

InvestingPro Insights

As Pluxee navigates through changing economic conditions, it's worth noting that one of its peers, Edenred (EDEN), has some intriguing financial metrics and analyst insights. According to InvestingPro data, Edenred boasts a notable revenue growth of 30.08% over the last twelve months as of Q2 2023. This growth is complemented by a gross profit margin of 43.97%, indicating a strong ability to translate sales into profits.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

However, Edenred's current P/E ratio stands at -9.79, reflecting a high earnings multiple when considering near-term earnings growth. This is in line with one of the InvestingPro Tips, which points out that Edenred is trading at a high P/E ratio relative to its near-term earnings growth. This suggests that investors may be paying a premium for the expected profitability of the company, which analysts predict will occur this year.

Furthermore, Edenred has demonstrated a commitment to shareholder returns, having maintained dividend payments for 13 consecutive years and raised its dividend for the last three consecutive years. This consistency could be a signal of financial stability and a shareholder-friendly policy, which may be of interest to investors seeking regular income.

For those considering a deeper dive into the financial health and future prospects of companies like Edenred, the full suite of InvestingPro Tips can provide additional insights. There are six more tips available for Edenred on InvestingPro, which can be accessed by using the coupon code "SFY24" to get an additional 10% off a 2-year InvestingPro+ subscription, or "SFY241" to get an additional 10% off a 1-year InvestingPro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.